Tealwood Asset Management Inc. Makes New $297,000 Investment in Waters Co. (NYSE:WAT)

Tealwood Asset Management Inc. acquired a new stake in shares of Waters Co. (NYSE:WAT) during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm acquired 800 shares of the medical instruments supplier’s stock, valued at approximately $297,000.

Other hedge funds also recently made changes to their positions in the company. Northwestern Mutual Wealth Management Co. raised its position in Waters by 96.8% during the second quarter. Northwestern Mutual Wealth Management Co. now owns 868 shares of the medical instruments supplier’s stock valued at $252,000 after purchasing an additional 427 shares in the last quarter. Toronto Dominion Bank lifted its position in Waters by 8.6% in the 2nd quarter. Toronto Dominion Bank now owns 26,234 shares of the medical instruments supplier’s stock worth $7,611,000 after buying an additional 2,086 shares during the last quarter. Dimensional Fund Advisors LP lifted its position in Waters by 21.0% in the 2nd quarter. Dimensional Fund Advisors LP now owns 448,304 shares of the medical instruments supplier’s stock worth $130,053,000 after buying an additional 77,951 shares during the last quarter. Barclays PLC grew its position in Waters by 34.8% during the third quarter. Barclays PLC now owns 159,995 shares of the medical instruments supplier’s stock valued at $57,579,000 after acquiring an additional 41,339 shares during the last quarter. Finally, Magnetar Financial LLC purchased a new position in shares of Waters during the second quarter worth approximately $2,944,000. 94.01% of the stock is owned by institutional investors.

Analyst Ratings Changes

WAT has been the subject of a number of research reports. Wells Fargo & Company upped their price objective on shares of Waters from $380.00 to $415.00 and gave the company an “overweight” rating in a research note on Monday, November 4th. TD Cowen raised their price objective on Waters from $363.00 to $410.00 and gave the company a “hold” rating in a research note on Monday, November 4th. Evercore ISI boosted their target price on Waters from $335.00 to $355.00 and gave the company an “in-line” rating in a research note on Tuesday, October 1st. Stifel Nicolaus raised their price target on Waters from $332.00 to $360.00 and gave the stock a “hold” rating in a research report on Monday, November 4th. Finally, Barclays lifted their price target on Waters from $330.00 to $360.00 and gave the stock an “underweight” rating in a research note on Monday, November 4th. One investment analyst has rated the stock with a sell rating, nine have given a hold rating, four have issued a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, Waters currently has a consensus rating of “Hold” and a consensus price target of $384.71.

Waters Stock Performance

Waters stock opened at $398.71 on Tuesday. Waters Co. has a fifty-two week low of $279.24 and a fifty-two week high of $401.00. The stock’s 50 day simple moving average is $377.07 and its two-hundred day simple moving average is $347.34. The company has a debt-to-equity ratio of 1.14, a quick ratio of 1.38 and a current ratio of 2.02. The stock has a market cap of $23.67 billion, a price-to-earnings ratio of 38.04, a PEG ratio of 6.92 and a beta of 1.01.

Waters (NYSE:WAT) last released its quarterly earnings results on Friday, November 1st. The medical instruments supplier reported $2.93 earnings per share for the quarter, beating the consensus estimate of $2.68 by $0.25. The company had revenue of $740.30 million for the quarter, compared to analyst estimates of $712.99 million. Waters had a return on equity of 49.93% and a net margin of 21.43%. The firm’s revenue was up 4.0% on a year-over-year basis. During the same period in the previous year, the company posted $2.84 earnings per share. As a group, analysts expect that Waters Co. will post 11.79 earnings per share for the current fiscal year.

Waters Company Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.